ReviewCurrent cardiology reports2006
Imaging cardiac neuronal function and dysfunction.
Review in Current cardiology reports, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 35 citations in OpenAlex.
- Cardiac sympathetic imaging in heart failure: Is revival possible?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021Article
- Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020Article
- From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.Antioxidants & redox signaling · 2019Review
- New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.International journal of molecular sciences · 2019Review
- Molecular Imaging of the Heart.Comprehensive Physiology · 2019Review
- PET/MR: Yet another Tesla?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017Review
- Recent Advances and Clinical Applications of PET Cardiac Autonomic Nervous System Imaging.Current cardiology reports · 2017Review
- Sympathetic nerve damage and restoration after ischemia-reperfusion injury as assessed by (11)C-hydroxyephedrine.European journal of nuclear medicine and molecular imaging · 2016Article
- Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs.BioMed research international · 2015Review
- Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?Current oncology reports · 2014Review
- Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2013Review
- Influence of myocardial region of interest definition on quantitative analysis of planar 123I-mIBG images.European journal of nuclear medicine and molecular imaging · 2013Article
- Multimodality and nanoparticles in medical imaging.Dalton transactions (Cambridge, England : 2003) · 2011Article
- Molecular imaging targets of cardiac remodeling.Current cardiology reports · 2009Review
- I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study.European journal of nuclear medicine and molecular imaging · 2008Article
- Early imaging in heart failure: exploring novel molecular targets.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2007Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, the importance of alterations of cardiac autonomic nerve function in the pathophysiology of heart diseases including heart failure, arrhythmia, ische-mic heart disease, and diabetes has been increasingly recognized. Several radiolabeled compounds have been synthesized for noninvasive imaging, including single photon emission CT and positron emission tomography (PET). The catecholamine analogue I-123 metaiodobenzylguanidine (MIBG) is the most commonly used tracer for mapping of myocardial presynaptic sympathetic innervation on a broad clinical basis. In addition, radiolabeled catecholamines and catecholamine analogues are available for PET imaging, which allows absolute quantification and tracer kinetics modeling. Postsynaptic receptor PET imaging added new insights into mechanisms of heart disease. These advanced imaging techniques provide noninvasive, repeatable in vivo information of autonomic nerve function in the human heart and are promising for providing profound insights into molecular pathophysiology, monitoring of treatment, and determination of individual outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.